Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 28 April 2005. doi:10.1136/ard.2004.032219
Annals of the Rheumatic Diseases 2005;64:1252-1256
Copyright © 2005 BMJ Publishing Group Ltd & European League Against Rheumatism

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ard.2004.032219v1
64/9/1252    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suresh, E
Right arrow Articles by Lambert, C M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suresh, E
Right arrow Articles by Lambert, C M

REVIEW

Combination treatment strategies in early rheumatoid arthritis

E Suresh , C M Lambert

Rheumatic Diseases Unit, Western General Hospital, Edinburgh, UK

Correspondence to:
Correspondence to:
Dr E Suresh
Rheumatology Department, Kettering General Hospital, Rothwell Road, Kettering, Northants NN16 8UZ, UK; dr_esuresh{at}hotmail.com


ABSTRACT
Combinations of disease modifying antirheumatic drugs (DMARDs) are increasingly being used in patients with early rheumatoid arthritis (RA) when long term results with sequential DMARD monotherapy are disappointing. Combination DMARD therapy may be more effective than monotherapy, and has no additional short term adverse events. The evidence for using combination DMARD therapy is still weak, however, and further trials are needed.


Abbreviations: ACR, American College of Rheumatology; DMARD, disease modifying antirheumatic drug; RA, rheumatoid arthritis; TNF, tumour necrosis factor

Keywords: combination therapy; early rheumatoid arthritis




This article has been cited by other articles:


Home page
DTBHome page
Combination therapy for early rheumatoid arthritis
DTB, November 1, 2006; 44(11): 81 - 85.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 BMJ Publishing Group Ltd & European League Against Rheumatism